[1] L Hemmmila, S Webb. Time2resolved fluorometry: an overview of the labels and core technologies for drug screening applications. Drug Discov.Today, 1997, 2(9): 373-381[2] H CLiu, Z MHe, Z Rosenwaks. Application of complementary DNA microarray (DNA chip) technology in the study of gene expression profiles during folliculognesis. Fertility and Sterility, 1999, 45(5): 533-543[3] R Storer. Solution-phase synthesis in combinatorial chemistry: Applications in drug discovery.Drug Discov. Today, 1996, 1(6): 248-254[4] D Josephr-Carthyk. Computational approaches to structure-based ligand design.Pharmacol. Therap., 1999, 84(2): 179-191[5] Y Hashimoto. Structural development of biological response modifiers based on thalidomide. Bioorg. Med. Chem., 2002, 10(3): 461-479[6] M A Sills. Future considerations in HTS: the acute effect of chronic dilemmas. 2.Drug Discov. Today, 1998, 3(7): 304-312[7] A Ebneth. Ion channel screening technologies: will they revolutionize drug discovery. Drug Discov. Today, 2002, 7(4): 227[8] S A Sundberg, A Chow, T Nikiforow, H GWada. Microchip-based systems for target validation and HTS. Drug Discov. Today, 2000, 5(12) (suppl): 92-103[9] L F Richard. RPRπs approach to high-speed parallel synthesis for lead generation. Drug Discov. Today, 1998, 3(11): 511-515[10] O Ramstrom, TBunyapaoboonsri, SLohmann, C Boone. Chemical biology of dynamic combinatorial libraries. Biochem. Biophys. Acta( BBA)/General subjects, 2002, 1572(2):178-866[11] TJoaquim, GM Eric. Innovative approaches to novel antibacterial drug discovery. Curr. Opin. Biotech., 1997, 8(6): 757-762[12] J Trias. The role of combichem in antibiotic discovery. Curr. Opin. Microbiol., 2001, 4(5): 520-525[13] J Marshall, D Jamous, J Nilsson. Reconciling thermodynamic and dynamic methods of computation of water-mass transformation rates.Deep Sea Res. Part I. Oceanograph. Res. Papers, 1999, 46(4): 545-572[14] J A Landro, L C A Taylor, W G Stirtan, D G Osterman, J Kristie. HTS in the new millennium: the role of pharmacology and flexibility. J.Pharmacol. Toxicol. Methods, 2000, 44(1): 273-289[15] N Terrtt. Combinatorial chemistry. Drug Discov. Today, 1999, 4(4): 187-188[16] D A Ahlquist, A P Shuber. Stool screening for colorectal cancer: evolution from occult blood to molecular markers. Clin. Chem. Acta, 2002,315(2) : 157-168[17] D A Smith. Induction and drug development. Euro. J. Pharm. Sci., 2000, 11(3): 185-189[18] 唐敖庆. 高分子反应统计理论. 北京:科学出版社, 1985. 2-10[19] T Abe. Derivationof the lattice boltzmann method by meansof the discrete ordinate methodfor the Boltzmann equation.J. Compt. Phys., 1997,131(1): 241-246[20] J Langowski, A Long. Computer systems for the prediction of xenobiotic metabolism. Adv. Drug Deliv. Rev., 2002, 54(3): 407-415[21] A P Shakeshaft, J A Bowman, R W F Sanson. Computers in community-based drug and alcohol clinical settings: are they acceptable to respondents. Drug Alcohol Depend., 1998, 50(2): 177-180 |